These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 17393074)
21. DePEGylation strategies to increase cancer nanomedicine efficacy. Kong L; Campbell F; Kros A Nanoscale Horiz; 2019 Mar; 4(2):378-387. PubMed ID: 32254090 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system. Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390 [TBL] [Abstract][Full Text] [Related]
23. Self-regulated multifunctional collaboration of targeted nanocarriers for enhanced tumor therapy. Gao H; Cheng T; Liu J; Liu J; Yang C; Chu L; Zhang Y; Ma R; Shi L Biomacromolecules; 2014 Oct; 15(10):3634-42. PubMed ID: 25308336 [TBL] [Abstract][Full Text] [Related]
24. Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Kohler N; Sun C; Fichtenholtz A; Gunn J; Fang C; Zhang M Small; 2006 Jun; 2(6):785-92. PubMed ID: 17193123 [TBL] [Abstract][Full Text] [Related]
25. Does a targeting ligand influence nanoparticle tumor localization or uptake? Pirollo KF; Chang EH Trends Biotechnol; 2008 Oct; 26(10):552-8. PubMed ID: 18722682 [TBL] [Abstract][Full Text] [Related]
26. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors. Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250 [TBL] [Abstract][Full Text] [Related]
27. Cholesterol-poly(ethylene) glycol nanocarriers for the transscleral delivery of sirolimus. Elsaid N; Somavarapu S; Jackson TL Exp Eye Res; 2014 Apr; 121():121-9. PubMed ID: 24530465 [TBL] [Abstract][Full Text] [Related]
28. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance. Chen S; Yang K; Tuguntaev RG; Mozhi A; Zhang J; Wang PC; Liang XJ Nanomedicine; 2016 Feb; 12(2):269-86. PubMed ID: 26707818 [TBL] [Abstract][Full Text] [Related]
29. Transferrin- and folate-modified, double-targeted nanocarriers for gene delivery. Jing F; Li D; Xu W; Liu Y; Wang K; Sui Z Pharm Biol; 2014 May; 52(5):570-4. PubMed ID: 24256214 [TBL] [Abstract][Full Text] [Related]
30. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review. Sultana S; Khan MR; Kumar M; Kumar S; Ali M J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288 [TBL] [Abstract][Full Text] [Related]
31. Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting. Kaaki K; Hervé-Aubert K; Chiper M; Shkilnyy A; Soucé M; Benoit R; Paillard A; Dubois P; Saboungi ML; Chourpa I Langmuir; 2012 Jan; 28(2):1496-505. PubMed ID: 22172203 [TBL] [Abstract][Full Text] [Related]
32. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Yu DH; Lu Q; Xie J; Fang C; Chen HZ Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444 [TBL] [Abstract][Full Text] [Related]
33. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine. Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405 [TBL] [Abstract][Full Text] [Related]
34. Overcoming the polyethylene glycol dilemma via pathological environment-sensitive change of the surface property of nanoparticles for cellular entry. Hama S; Itakura S; Nakai M; Nakayama K; Morimoto S; Suzuki S; Kogure K J Control Release; 2015 May; 206():67-74. PubMed ID: 25770398 [TBL] [Abstract][Full Text] [Related]
35. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies. Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and characterization of pH-sensitive poly(itaconic acid)-poly(ethylene glycol)-folate-poly(l-histidine) micelles for enhancing tumor therapy and tunable drug release. Sun Y; Li Y; Nan S; Zhang L; Huang H; Wang J J Colloid Interface Sci; 2015 Nov; 458():119-29. PubMed ID: 26210102 [TBL] [Abstract][Full Text] [Related]
37. The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles. Xin H; Sha X; Jiang X; Chen L; Law K; Gu J; Chen Y; Wang X; Fang X Biomaterials; 2012 Feb; 33(5):1673-81. PubMed ID: 22133551 [TBL] [Abstract][Full Text] [Related]
38. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. Schöttler S; Becker G; Winzen S; Steinbach T; Mohr K; Landfester K; Mailänder V; Wurm FR Nat Nanotechnol; 2016 Apr; 11(4):372-7. PubMed ID: 26878141 [TBL] [Abstract][Full Text] [Related]
39. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery. Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665 [TBL] [Abstract][Full Text] [Related]
40. Mixed micelles of lipoic acid-chitosan-poly(ethylene glycol) and distearoylphosphatidylethanolamine-poly(ethylene glycol) for tumor delivery. Elsaid Z; Taylor KM; Puri S; Eberlein CA; Al-Jamal K; Bai J; Klippstein R; Wang JT; Forbes B; Chana J; Somavarapu S Eur J Pharm Sci; 2017 Apr; 101():228-242. PubMed ID: 28163163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]